Reminder: Generex Investor Conference Call Friday, November 29, 2019


You May Also Like

Cempra’s Fusidic Acid Achieves Primary Endpoint in Phase 3 Study of ABSSSI

—Fusidic acid met primary endpoint and secondary efficacy endpoints— —Fusidic acid well tolerated in ...

Aquinox Announces Appointment of Dr. Barbara Troupin as Chief Medical Officer

VANCOUVER, British Columbia, Oct. 03, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), ...